Literature DB >> 3980095

Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus.

L D Gray, A S Kreger.   

Abstract

An extracellular cytolytic toxin produced by the halophilic bacterium Vibrio vulnificus was isolated free of detectable contamination with medium constituents and other bacterial products by sequential ammonium sulfate precipitation, gel filtration with Sephadex G-75, hydrophobic interaction chromatography with phenyl-Sepharose CL-4B, and isoelectric focusing in an ethylene glycol density gradient. The cytolysin is a heat-labile, hydrophobic protein that is inhibited by large amounts of cholesterol, is partially inactivated by proteases and trypan blue, has a molecular weight (estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and by amino acid analysis) of ca. 56,000, and has an isoelectric point of ca. 7.1. The first 10 amino-terminal amino acid residues of the cytolysin are Gln-Glu-Tyr-Val-Pro-Ile-Val-Glu-Lys-Pro. Lysis of mouse erythrocytes by the purified cytolysin is a multi-hit, at least two-step process consisting of a temperature-independent, toxin-binding step, followed by a temperature-dependent, membrane-perturbation step(s). In addition to possessing cytolytic activity against erythrocytes from 17 animal species and against Chinese hamster ovary cells in tissue culture, the purified cytolysin preparation was lethal for mice (ca. 3 micrograms/kg, intravenous 50% lethal dose) and had vascular permeability factor activity in guinea pig skin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3980095      PMCID: PMC261915          DOI: 10.1128/iai.48.1.62-72.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Isolation and composition of staphylococcal alpha toxin.

Authors:  A W BERNHEIMER; L L SCHWARTZ
Journal:  J Gen Microbiol       Date:  1963-03

2.  Evidence for a one-hit theory in the immune bactericidal reaction and demonstration of a multi-hit response for hemolysis by streptolysin O and Clostridium perfringens theta-toxin.

Authors:  K Inoue; Y Akiyama; T Kinoshita; Y Higashi; T Amano
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

3.  Tissue invasion by unnamed marine vibrios.

Authors:  C R Fernandez; G A Pankey
Journal:  JAMA       Date:  1975-09-15       Impact factor: 56.272

4.  Clinical manifestations of halophilic non-cholera Vibrio infections.

Authors:  S B Thorsteinsson; J N Minuth; D M Musher
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

5.  Fulminating vibrio parahemolyticus septicemia. A syndrome of erythemia multiforme, hemolytic anemia, and hypotension.

Authors:  N Zide; J Davis; N J Ehrenkranz
Journal:  Arch Intern Med       Date:  1974-03

6.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

Authors:  K Weber; J R Pringle; M Osborn
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Halophilic Vibrio species isolated from blood cultures.

Authors:  D G Hollis; R E Weaver; C N Baker; C Thornsberry
Journal:  J Clin Microbiol       Date:  1976-04       Impact factor: 5.948

9.  Characteristics of streptolysin O action.

Authors:  T D Oberley; J L Duncan
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

10.  Properties of purified pneumococcal hemolysin.

Authors:  M K Johnson
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

View more
  56 in total

1.  Purification and characterization of a vulnificolysin-like cytolysin produced by Vibrio tubiashii.

Authors:  M H Kothary; R B Delston; S K Curtis; B A McCardell; B D Tall
Journal:  Appl Environ Microbiol       Date:  2001-08       Impact factor: 4.792

2.  Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin.

Authors:  J J Fan; C P Shao; Y C Ho; C K Yu; L I Hor
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Pulmonary damage by Vibrio vulnificus cytolysin.

Authors:  J W Park; S N Ma; E S Song; C H Song; M R Chae; B H Park; R W Rho; S D Park; H R Kim
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Cloning and sequence analysis of a novel hemolysin gene (vllY) from Vibrio vulnificus.

Authors:  T M Chang; Y C Chuang; J H Su; M C Chang
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

5.  Polymerase chain reaction identification of Vibrio vulnificus in artificially contaminated oysters.

Authors:  W E Hill; S P Keasler; M W Trucksess; P Feng; C A Kaysner; K A Lampel
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

6.  Low density lipoprotein inactivates Vibrio vulnificus cytolysin through the oligomerization of toxin monomer.

Authors:  Kwang-Hyun Park; Haet-Bit Yang; Hyung-Gue Kim; Young-Rae Lee; Hyoun Hur; Jong-Soo Kim; Bon-Sun Koo; Myung-Kwan Han; Jong-Hyun Kim; Young-Ju Jeong; Jong-Suk Kim
Journal:  Med Microbiol Immunol       Date:  2004-11-20       Impact factor: 3.402

7.  The type IV leader peptidase/N-methyltransferase of Vibrio vulnificus controls factors required for adherence to HEp-2 cells and virulence in iron-overloaded mice.

Authors:  R N Paranjpye; J C Lara; J C Pepe; C M Pepe; M S Strom
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice.

Authors:  A C Wright; J G Morris
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Genetic, immunological, and cytotoxic comparisons of Legionella proteolytic activities.

Authors:  F D Quinn; M G Keen; L S Tompkins
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

10.  Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus.

Authors:  A C Wright; J G Morris; D R Maneval; K Richardson; J B Kaper
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.